Zobrazeno 1 - 10
of 18
pro vyhledávání: '"Rita CLERICO"'
Autor:
Ugo BOTTONI, Rita CLERICO, Antonio G. RICHETTA, Vincenzo PANASITI, Paola CORSETTI, Vincenzo ROBERTI, Giovanni PAOLINO, Elisa MOLITERNI, Sara GRASSI, Stefano CALVIERI
Publikováno v:
Italian Journal of Dermatology and Venereology. 158
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::0128bbd3be7f7d73c3e69cac8fed28b9
https://doi.org/10.23736/s2784-8671.23.07424-8
https://doi.org/10.23736/s2784-8671.23.07424-8
Autor:
Giovanni, Paolino, Dario, Didona, Rita, Clerico, Paola, Corsetti, Marina, Ambrifi, Ugo, Bottoni, Stefano, Calvieri
Publikováno v:
Cutis. 97(6)
Imatinib mesylate (IM) represents the first-line treatment of patients with chronic myeloid leukemia (CLM) or gastrointestinal stromal tumor (GIST). It presents several side effects. However, less than 10% are nonhematologic including nausea, vomitin
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::8baadd2c416b9d39d358692f3d8ffab7
https://pubmed.ncbi.nlm.nih.gov/27416091
https://pubmed.ncbi.nlm.nih.gov/27416091
Autor:
Giovanni Paolino, Paola Corsetti, Rita Clerico, Marina Ambrifi, Stefano Calvieri, Ugo Bottoni, Valeria Devirgiliis
Publikováno v:
Medical Oncology. 29:2978-2984
In the literature, there are some papers report- ing on patients with metastatic melanoma from an unknown primary lesion (MUP). The pathogenesis of this phenomenon and the prognosis of these patients are still debatable. Therefore, we reviewed our ca
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::33a850d1f6f90d67a06ae70f6a9cf7c3
https://doi.org/10.1007/s12032-012-0217-9
https://doi.org/10.1007/s12032-012-0217-9
Autor:
Stefano Calvieri, Rita Clerico, Carlo Mattozzi, Antonio Giovanni Richetta, Tamara Lazic, Carmen Cantisani
Publikováno v:
Recent Patents on Inflammation & Allergy Drug Discovery. 6:65-69
Imiquimod is an immune response modifier that stimulates the patient's own immune system to release various chemical substances, such as interferon and interleukin-12. Although, approved by the United States Food and Drug Administration since 1997 as
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::e18faf93e70abef459deb05cc19ab644
https://doi.org/10.2174/187221312798889301
https://doi.org/10.2174/187221312798889301
Autor:
PIETRO CURATOLO, MONICA MANCINI, ARIANNA RUGGIERO, RITA CLERICO, PIERO DI MARCO, STEFANO CALVIERI
Publikováno v:
Dermatologic Surgery. 34:839-842
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::d57b77bbd3a70d8a9d70ffbc7e6ee693
https://doi.org/10.1097/00042728-200806000-00024
https://doi.org/10.1097/00042728-200806000-00024
Autor:
Giovanni Paolino, Carmen Cantisani, Marina Ambrifi, Rita Clerico, Dario Didona, Paola Corsetti, Marcello Albanesi, Paolo Lido, A. Brachini, Antonio Giovanni Richetta, Stefano Calvieri, Ugo Bottoni
Summary Background An association between autoimmune disease and malignant melanoma (MM) has often been reported in the literature as a positive prognostic factor for MM. Consequently, we evaluated the influence of different autoimmune diseases on th
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6101fc06184aeba9959f9122d7232905
http://hdl.handle.net/11573/791188
http://hdl.handle.net/11573/791188
Autor:
Carmen Cantisani, Dario Didona, Federico Venuta, Giovanni Paolino, Paola Corsetti, Antonio Giovanni Richetta, Teresa Lopez, Rita Clerico, Marina Ambrifi, Stefano Calvieri, Ugo Bottoni
Background: The lung is the second most common site for metastatic malignant melanoma, with a poor prognosis. In this regard, identify clinicopathological predictors for Melanoma Lung Metastases (MLM) plays a pivotal role in clinical practice. Method
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::864140127a0cc635389239a288410491
http://hdl.handle.net/11573/1392380
http://hdl.handle.net/11573/1392380
Autor:
Antonio Giovanni Richetta, Giovanni Paolino, Carmen Cantisani, Paola Corsetti, Marina Ambrifi, Rita Clerico, Stefano Calvieri, Ugo Bottoni
In the absence of risk factors, thin melanomas (TM) present a long-term survival; however, recurrences may occur. We describe the predictive clinicopathological features of patients with metastatic TM. Kaplan-Meier product was performed for the survi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cbcb095f698a4aa128b45f0a409c0ba8
http://hdl.handle.net/11573/791130
http://hdl.handle.net/11573/791130
Autor:
Valeria Devirgiliis, R.G. Borroni, Monica Mancini, Vincenzo Panasiti, M. Rossi, Maurizio Martelli, Mario Venditti, Michela Curzio, Stefano Calvieri, Ugo Bottoni, Salvatore Delia, Rita Clerico
Publikováno v:
Journal of Infection. 53:e181-e183
Among patients with cutaneous T-cell lymphoma (CTCL), sepsis and pulmonary infections are the first cause of death. We report on a patient with CTCL who, after more than 10 years of aggressive antineoplastic treatments, showed extensive pulmonary inf
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1d00c11684120798b7f278a328068c6b
https://doi.org/10.1016/j.jinf.2005.12.019
https://doi.org/10.1016/j.jinf.2005.12.019
Autor:
Marina Ambrifi, Rita Clerico, Giovanni Paolino, Paola Corsetti, Stefano Calvieri, Ugo Bottoni
Brain metastases (BM) are one of the most frequent neurological complications of cancers. Melanoma is the third most common tumor to metastasize to the brain with a reported incidence of 10–40 %, and many patients have subclinical BM (>73 %). We co
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2664e5eb64140fb9f3365778173e5bd7
http://hdl.handle.net/11573/508780
http://hdl.handle.net/11573/508780